bromodeoxyuridine has been researched along with azd 6244 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ammoun, S; Hanemann, CO; Hilton, DA; Matthies, C; Ristic, N | 1 |
Denton, CL; Gustafson, DL | 1 |
2 other study(ies) available for bromodeoxyuridine and azd 6244
Article | Year |
---|---|
Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244.
Topics: Antineoplastic Agents; Benzimidazoles; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; Humans; Immunoblotting; Immunohistochemistry; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Neurilemmoma; Phosphorylation; Platelet-Derived Growth Factor; Schwann Cells | 2010 |
Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice.
Topics: Animal Structures; Animals; Area Under Curve; Benzimidazoles; Bromodeoxyuridine; Cell Death; Cell Line, Tumor; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Humans; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Protein Kinase Inhibitors; Tissue Distribution; Xenograft Model Antitumor Assays | 2011 |